Sort by
Items per page

Send to

Choose Destination

Links from Books

Items: 6


L1-CAM-targeted antibody therapy and (177)Lu-radioimmunotherapy of disseminated ovarian cancer.

Fischer E, Grünberg J, Cohrs S, Hohn A, Waldner-Knogler K, Jeger S, Zimmermann K, Novak-Hofer I, Schibli R.

Int J Cancer. 2012 Jun 1;130(11):2715-21. doi: 10.1002/ijc.26321. Epub 2011 Aug 29.


L1-CAM as a target for treatment of cancer with monoclonal antibodies.

Weidle UH, Eggle D, Klostermann S.

Anticancer Res. 2009 Dec;29(12):4919-31. Review.


Copper-67 radioimmunotherapy and growth inhibition by anti-L1-cell adhesion molecule monoclonal antibodies in a therapy model of ovarian cancer metastasis.

Knogler K, Grünberg J, Zimmermann K, Cohrs S, Honer M, Ametamey S, Altevogt P, Fogel M, Schubiger PA, Novak-Hofer I.

Clin Cancer Res. 2007 Jan 15;13(2 Pt 1):603-11.


In vivo evaluation of 177Lu- and 67/64Cu-labeled recombinant fragments of antibody chCE7 for radioimmunotherapy and PET imaging of L1-CAM-positive tumors.

Grünberg J, Novak-Hofer I, Honer M, Zimmermann K, Knogler K, Bläuenstein P, Ametamey S, Maecke HR, Schubiger PA.

Clin Cancer Res. 2005 Jul 15;11(14):5112-20.


A comparison of targeting of neuroblastoma with mIBG and anti L1-CAM antibody mAb chCE7: therapeutic efficacy in a neuroblastoma xenograft model and imaging of neuroblastoma patients.

Hoefnagel CA, Rutgers M, Buitenhuis CK, Smets LA, de Kraker J, Meli M, Carrel F, Amstutz H, Schubiger PA, Novak-Hofer I.

Eur J Nucl Med. 2001 Mar;28(3):359-68.


Supplemental Content

Support Center